drugset

drugset / Trial / NCT00703781

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

NCT00703781 ↗

Phase 3 Completed 126 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Timeline

Start: 2008-06
Primary completion: 2008-11
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bromfenac	Other / unclassified	0.09 %	—

Indications